Over 32,000 People Dead in Brazil Following COVID-19 Vaccines According to Official Media Report

By Brian Shilhavy
Global Research, August 20, 2021
Health Impact News 19 August 2021
Region:
Theme:

All Global Research articles can be read in 51 languages by activating the “Translate Website” drop down menu on the top banner of our home page (Desktop version). 

Visit and follow us on Instagram at @crg_globalresearch.

***

A Health Impact News reader from Brazil has alerted us to official media reports stating that during a 5-month period, over 32,000 people in Brazil have died following a COVID-19 injection.  [GR Editor’s Note. Yet to be confirmed]

Currently in Brazil, the following vaccines are authorized for use: AstraZeneca/Oxford, Pfizer/BioNTech, Coronavac (also called Sinovac), J&J/Janssen, and Butanvac.

The report was published on uol.com.br, which reportedly has about the same number of pageviews as CNN.com, according to data from SimilarWeb. It is so big, that ICANN has given its own domain: .uol.

Despite these high amounts of deaths following vaccination, the report states:

“Vaccination is still the best way to control the disease.”

But even these cases of deaths following COVID-19 injections might be under-reported, as the country’s state news agency reported in July that in the small state of Distrito Federal, at least 711 died after taking the first experimental vaccine, while another 263 people died after taking two doses of the experimental vaccines. (Source.)

Brazil’s state news agency reports:

Vaccination does not prevent re-infection or the evolution to more serious conditions, including death. Therefore, the Health Secretary stressed the importance of keeping the prevention measures against the new coronavirus.

“We are always alerting people to wear masks, wash their hands, use alcohol gel, and avoid crowds. Even if we are vaccinated, we can acquire the virus and have complications”, he declared. (Source.)

Parts of this article were translated by DeepL.

*

Note to readers: Please click the share buttons above or below. Follow us on Instagram, @crg_globalresearch. Forward this article to your email lists. Crosspost on your blog site, internet forums. etc.

Featured image is from HIN
Articles by: Brian Shilhavy

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]

www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]